Dr. Douglas Orr, MD
Claim this profileMary Crowley Cancer Research
About Douglas Orr, MD
Education:
- Received an MD from Vanderbilt University Medical School.
Experience:
- Specializes in medical oncology and hematology.
- Associated with Mary Crowley Cancer Research, focusing on innovative clinical trials.
- Experienced in early phase solid tumor and hematology trials, including first-in-human trials.
Area of expertise
Solid Tumors
Douglas Orr, MD has run 11 trials for Solid Tumors. Some of their research focus areas include:
Lung Cancer
Douglas Orr, MD has run 6 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mary Crowley Cancer Research
Mary Crowley Medical Research Center
Clinical Trials Douglas Orr, MD is currently running
EU101
for Solid Cancers
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Recruiting
1 award
Phase 1 & 2
10 criteria
SW-682
for Solid Tumors
This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Recruiting
1 award
Phase 1
6 criteria
More about Douglas Orr, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Douglas Orr, MD has experience with
- Pembrolizumab
- ELU001
- PEEL-224
- PRO1184
- LCB84
- Anti-PD-1 Monoclonal Antibody
Breakdown of trials Douglas Orr, MD has run
Lung Cancer
Pancreatic Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas Orr, MD specialize in?
Douglas Orr, MD focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are NF2 positive.
Is Douglas Orr, MD currently recruiting for clinical trials?
Yes, Douglas Orr, MD is currently recruiting for 6 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Douglas Orr, MD has studied deeply?
Yes, Douglas Orr, MD has studied treatments such as Pembrolizumab, ELU001, PEEL-224.
What is the best way to schedule an appointment with Douglas Orr, MD?
Apply for one of the trials that Douglas Orr, MD is conducting.
What is the office address of Douglas Orr, MD?
The office of Douglas Orr, MD is located at: Mary Crowley Cancer Research, Dallas, Texas 75230 United States. This is the address for their practice at the Mary Crowley Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.